(Q39289571)

10 September 2017

title

Fetal growth, major malformations, and minor anomalies in infants born to women receiving valproic acid (English)

1 reference

10 September 2017

Jäger-Roman E

1 reference

10 September 2017

Deichl A

1 reference

10 September 2017

Jakob S

1 reference

10 September 2017

Hartmann AM

1 reference

10 September 2017

Koch S

1 reference

10 September 2017

Rating D

1 reference

10 September 2017

Steldinger R

1 reference

10 September 2017

Nau H

1 reference

10 September 2017

Helge H

1 reference

10 September 2017

language of work or name

English

0 references

publication date

1 June 1986

1 reference

The Journal of Pediatrics

10 September 2017

published in

1 reference

10 September 2017

volume

108

1 reference

10 September 2017

1 reference

10 September 2017

page(s)

997-1004

1 reference

Teratogenicity of valproic acid

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980949-0

Possible teratogenicity of valproic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980949-0

Teratogenic effects of anticonvulsants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980949-0

Possible teratogenic effect of valproic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980949-0

Possible teratogenic effect of valproate during pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980949-0

The fetal valproate syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980949-0

Anti-epileptic agents during pregnancy. A prospective study on the course of pregnancy, malformations and child development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980949-0

Valproic acid in the perinatal period: decreased maternal serum protein binding results in fetal accumulation and neonatal displacement of the drug and some metabolites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980949-0

Clinical assessment of gestational age in the newborn infant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980949-0

Intrauterine growth of live-born Caucasian infants at sea level: standards obtained from measurements in 7 dimensions of infants born between 25 and 44 weeks of gestation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980949-0

Growth retardation, dysmorphic facies and minor malformations following massive exposure to phenobarbitone in utero.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980949-0

Teratogenic and pharmacokinetic studies of primidone during pregnancy and in the offspring of epileptic women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980949-0

Fetal head growth retardation associated with maternal antiepileptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980949-0

Sodium valproate: a review of its pharmacological properties and therapeutic efficacy in epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980949-0

Concentrations of free fatty acids in maternal and umbilical cord blood during elective Caesarean section

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980949-0

Valproic Acid Binding to Human Serum Albumin and Determination of Free Fraction in the Presence of Anticonvulsants and Free Fatty Acids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980949-0

Valproic acid dosage and plasma protein binding and clearance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980949-0

A new model for embryotoxicity testing: teratogenicity and pharmacokinetics of valproic acid following constant-rate administration in the mouse using human therapeutic drug and metabolite concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980949-0

Risks to the offspring of women treated with hydantoin anticonvulsants, with emphasis on the fetal hydantoin syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980949-0

The fetal trimethadione syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980949-0

10.1016/S0022-3476(86)80949-0

7 January 2021

Identifiers

DOI

1 reference

10 September 2017

1 reference